Wire · opportunities
FDA clears next-gen peripheral thrombectomy device
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 13 August 2026 · Fusion42 review
Vesalio has received FDA clearance for its next-generation peripheral mechanical thrombectomy device, the pVasc NET, featuring a dual-layer distal filter for improved emboli capture during minimally invasive procedures in peripheral blood vessels.
This Wire brief sits within Fusion42's coverage of Medtech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.
◆ ◆ The Wire takeaway
You can now position your medtech startup to incorporate or compete with more sophisticated thrombectomy tech in peripheral vascular care as FDA clearance lowers barriers for innovative devices like Vesalio’s pVasc NET.
◆ Related on Wire
◆ Topics